BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
-26.78%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$765M
AUM Growth
+$765M
(-33%)
Cap. Flow
-$45.3M
Cap. Flow
% of AUM
-5.91%
Top 10 Holdings %
Top 10 Hldgs %
52.72%
Holding
58
New
1
Increased
22
Reduced
25
Closed
3
Top Buys
| 1 |
Arcus Biosciences
RCUS
|
$14.6M |
| 2 |
Kura Oncology
KURA
|
$10.7M |
| 3 |
Merus
MRUS
|
$8.4M |
| 4 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$6.86M |
| 5 |
Verastem
VSTM
|
$5.13M |
Top Sells
| 1 |
Ionis Pharmaceuticals
IONS
|
$27.6M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$22M |
| 3 |
RGLS
Regulus Therapeutics
RGLS
|
$11.8M |
| 4 |
Xencor
XNCR
|
$8.83M |
| 5 |
KalVista Pharmaceuticals
KALV
|
$7.04M |
Sector Composition
| 1 | Healthcare | 83.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCXI
1
DELISTED
ChemoCentryx, Inc.
CCXI
| $73M | 9.54% | 6,687,523 -86,237 | -1% | -$941K |
|
|
ARRY
2
DELISTED
Array Biopharma Inc
ARRY
| $67.6M | 8.83% | 4,744,062 -1,546,524 | -25% | -$22M |
|
|
3
Merus
MRUS
$4.98B
| $63.2M | 8.26% | 4,514,913 +600,000 | +15% | +$8.4M |
|
|
4
Kura Oncology
KURA
$686M
| $39M | 5.09% | 2,775,156 +759,300 | +38% | +$10.7M |
|
|
BPMC
5
DELISTED
Blueprint Medicines
BPMC
| $31M | 4.05% | 574,967 -23,300 | -4% | -$1.26M |
|
|
MRTX
6
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $29.2M | 3.82% | 688,851 -34,471 | -5% | -$1.46M |
|
7
Cytokinetics
CYTK
$4.23B
| $26.2M | 3.43% | 4,150,639 -1,036,200 | -20% | -$6.55M |
|
|
8
Arcus Biosciences
RCUS
$1.13B
| $26M | 3.39% | 2,411,623 +1,352,783 | +128% | +$14.6M |
|
|
FPRX
9
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $25.9M | 3.38% | 2,781,346 -599,771 | -18% | -$5.58M |
|
10
Xoma
XOMA
$392M
| $22.4M | 2.92% | 1,769,029 +266,229 | +18% | +$3.37M |
|
|
11
Xencor
XNCR
$580M
| $21.5M | 2.8% | 593,465 -244,073 | -29% | -$8.83M |
|
12
AC Immune
ACIU
$205M
| $21.1M | 2.75% | 2,230,027 +212,527 | +11% | +$2.01M |
|
|
INFI
13
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $20.6M | 2.69% | 17,426,968 +2,194,700 | +14% | +$2.59M |
|
|
PVLA
14
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $19.8M | 2.59% | 7,457,921 +1,857,400 | +33% | +$4.94M |
|
|
ARQL
15
DELISTED
Arqule Inc
ARQL
| $17.3M | 2.26% | 6,230,418 +402,516 | +7% | +$1.11M |
|
|
CNCE
16
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $14.4M | 1.89% | 1,150,445 -441,693 | -28% | -$5.54M |
|
17
AnaptysBio
ANAB
$569M
| $14.1M | 1.84% | 220,265 -30,000 | -12% | -$1.91M |
|
|
MTEM
18
DELISTED
Molecular Templates, Inc.
MTEM
| $13.6M | 1.78% | 3,364,421 +576,792 | +21% | +$2.33M |
|
|
CALA
19
DELISTED
Calithera Biosciences, Inc
CALA
| $13.2M | 1.73% | 3,298,282 +754,282 | +30% | +$3.02M |
|
|
DRNA
20
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $13M | 1.7% | 1,215,727 +63,654 | +6% | +$680K |
|
21
Galmed Pharmaceuticals
GLMD
$6.96M
| $12.8M | 1.68% | 1,878,508 +116,941 | +7% | +$799K |
|
|
22
Verastem
VSTM
$569M
| $11.8M | 1.54% | 3,513,994 +1,527,000 | +77% | +$5.13M |
|
|
BLRX
23
BioLineRX
BLRX
$16.2M
| $11.4M | 1.49% | 25,995,575 | – | – |
|
24
Xenon Pharmaceuticals
XENE
$2.98B
| $11.3M | 1.48% | 1,788,774 +623,221 | +53% | +$3.93M |
|
25
Protagonist Therapeutics
PTGX
$3.67B
| $11M | 1.44% | 1,639,458 -978,509 | -37% | -$6.59M |
|